The strong adoption at AAIC suggests growing commercial traction for NULISA in Alzheimer's research, but this is a conference update, not a revenue catalyst. Monitor for subsequent partnership or commercial deals.
Price Chart
Executive Summary
Alamar Biosciences announced that its NULISA platform will be featured in over 140 poster and session presentations at the Alzheimer's Association International Conference (AAIC), more than four times the number at the prior conference. This signals growing adoption of the platform among Alzheimer's researchers, though the announcement is a conference-related update without direct financial impact.
Key Facts
- More than 140 posters and presentations featuring NULISA at AAIC 2026, over 4x the number at the previous AAIC.
- Alamar will host a workshop on July 14, 2026, highlighting eMTBR-Tau and BD-pTau217 assays.
- The press release contains no financial data, revenue, EPS, guidance, or deal values.
Financial Impact
No financial figures provided; the event is a conference presence with no direct revenue impact.
Risk Factors
- Intense competition in the proteomics market.
- Dependence on research funding and academic spending.
- No direct revenue or earnings impact from this announcement.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3325399 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 12d ago | 144 | $27.42 | awaiting T+60 | — | $30.39 (−10.83%) |
Oct 14, 2026 12d ago | 144 | $27.42 | awaiting T+60 | — | $30.39 (−10.83%) |
Oct 14, 2026 12d ago | 144 | $27.42 | awaiting T+60 | — | $30.39 (+10.83%) |
Oct 5, 2026 21d ago | Press Release | $32.26 | awaiting T+60 | — | $30.39 (−5.80%) |
Sep 24, 2026 4w ago | Press Release | $32.80 | awaiting T+60 | — | $30.39 (−7.35%) |
Sep 1, 2026 7w ago | 8-K | $30.49 | awaiting T+60 | — | $30.39 (−0.33%) |
Aug 10, 2026 11w ago | 8-K | $36.57 | awaiting T+60 | — | $30.39 (−16.90%) |
Jul 13, 2026 15w ago | Press Release | $27.40 $32.26 | ▲ +17.74% | ▲ +13.74% | $30.39 (+10.91%) |
Jul 10, 2026 15w ago | Press Release | $28.42 $38.13 | ▲ +34.17% | ▲ +31.53% | $30.39 (+6.93%) |
May 8, 2026 24w ago | 8-K | $23.96 $27.11 | ▲ +13.15% | ▲ +8.31% | $30.39 (+26.84%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers